Abstract
Hello, I'm Dr. Alex Jimenez. Welcome to our educational post where we will embark on an in-depth exploration of hip osteoarthritis (OA). This condition is more than just a source of pain; it's a significant global health issue with far-reaching consequences on overall well-being and mortality. We will begin by examining the staggering global statistics on hip OA, highlighting its increasing prevalence and the substantial burden it places on individuals and healthcare systems.
From there, we'll journey into the hip's intricate anatomy, understanding the structures involved and how their dysfunction leads to the characteristic pain patterns of OA. I will share insights from my clinical practice on how to perform a thorough hip examination and differentiate hip joint pathology from other sources of pain, like sacroiliac joint or lumbar spine issues.
We will then transition to a comprehensive discussion of treatment options, starting with the foundational role of physical therapy and how integrative chiropractic care complements this approach by optimizing biomechanics. We'll critically evaluate traditional treatments, such as corticosteroid injections, against modern, evidence-based regenerative therapies, such as platelet-rich plasma (PRP). Supported by the latest systematic reviews and randomized controlled trials, we'll compare their effectiveness, duration of relief, and long-term outcomes.
I'll also share a compelling case study from my own experience treating a high-level athlete, illustrating how an integrative, patient-centered approach can lead to remarkable recovery. Finally, we'll look toward the future, discussing optimal dosing, injection frequency, and the exciting potential of advanced biologics in managing hip OA. This post is designed to provide you with a clear, narrative-driven understanding of hip OA, grounded in cutting-edge research and extensive clinical expertise.
The Global Burden of Hip Osteoarthritis
As a clinician who sees the effects of musculoskeletal conditions daily, the growing prevalence of hip osteoarthritis (OA) is a profound concern. It's not just that we feel we're seeing more of it in the clinic; the data confirms it. The Global Burden of Disease study, a monumental research effort spanning decades, provides a clear picture. Looking at data from 1990 to 2019, the findings are startling. The global prevalence of symptomatic hip OA more than doubled, soaring from approximately 740,000 cases to 1.6 million.
When we analyze the geographical distribution of these cases, distinct patterns emerge. North America, particularly the United States, shows a very high incidence. We see similar trends across Europe, Australia, New Zealand, and parts of South America, like Argentina and Uruguay. Interestingly, data point to high-income regions in North America having the highest overall rates of hip OA. This might be counterintuitive, but it could be linked to specific lifestyle and activity patterns prevalent in these areas, which can contribute to joint wear and tear over time.
This isn't just about numbers; it's about people's lives. The impact of hip OA extends far beyond joint pain. Metrics like Disability-Adjusted Life Years (DALYs), which measure the years of healthy life lost to a disability, continue to rise for hip OA. Symptomatic arthritis of the hip and knee significantly reduces a person's physical activity. This sedentary trend is a critical health risk. A 2015 study with a 16-year follow-up period delivered some sobering statistics:
Individuals with hip OA had a 14% increase in all-cause mortality.
They also faced a 24% increase in cardiovascular disease mortality.
These findings underscore a crucial point I emphasize in my practice: hip OA is a systemic issue. The reduction in activity it causes is a direct threat to a person's cardiovascular health and overall longevity. This is why addressing hip pain effectively is not just about pain relief; it's about preserving life and health.
Understanding the Anatomy and Clinical Presentation of Hip Pain
To effectively treat a condition, we must first deeply understand the structure and function of the area involved. The hip is a marvel of biomechanical engineering, but its complexity also makes it susceptible to various pain-generating issues.
The Bony and Soft Tissue Structures
The core of the hip joint is the articulation between the head of the femur (the thigh bone) and the acetabulum (the socket in the pelvis). This ball-and-socket joint is designed for a wide range of motion and significant weight-bearing. Surrounding this primary joint are other critical structures that play a role in stability and movement:
The greater trochanter is a bony prominence on the side of the femur where key muscles like the gluteus medius and minimus attach.
The sacroiliac (SI) joint, which connects the pelvis to the spine, can be a common source of low back and buttock pain.
This is just the bony framework. Layered on top are numerous muscles, ligaments, nerves, and blood vessels, all of which can be sources of pain. This intricate network is why a patient presenting with "hip pain" requires a careful and detailed diagnostic process.
Deciphering Pain Patterns
In my clinical experience, patients with true intra-articular hip joint pathology, like OA, most commonly report pain in the anterior groin and inner thigh. Many describe a "C-sign," where they cup their hand in a "C" shape over the side of their hip to indicate the location of their discomfort.
However, pain referral patterns can be misleading. While anterior groin pain is classic for hip joint issues, I've seen many cases—perhaps up to 10%—where primary hip joint pathology presents as posterior buttock pain. This is a critical clinical pearl. If you are treating a patient for what appears to be an SI joint issue, piriformis syndrome, or a high hamstring strain, and they are not responding to targeted treatment, it is essential to investigate the hip joint itself. It's surprisingly easy to overlook subtle bone spurs or early degenerative changes on imaging if you aren't specifically looking for them.
The Comprehensive Hip Examination
A precise diagnosis hinges on a thorough physical examination. While we have standard ranges of motion for the hip, the most revealing movements for diagnosing intra-articular hip pathology are internal and external rotation. A healthy hip typically has around 30-40 degrees of internal rotation and 40-60 degrees of external rotation. A significant, painful limitation in these movements is a strong indicator of a problem within the joint itself.
Several orthopedic tests help us pinpoint the source of pain:
Log Roll Test: This involves passively rolling the patient's leg internally and externally while the patient lies supine. It is a very good test for assessing hip joint irritability with minimal stress on other structures.
FABER Test (Flexion, Abduction, External Rotation): This test can reproduce pain from the hip joint and also stress the sacroiliac joint. When I perform this maneuver, I always ask the patient, "Where exactly are you feeling this?" This helps differentiate anterior hip pain (suggesting hip joint pathology) from posterior hip pain (suggesting SI joint involvement).
FADIR Test (Flexion, Adduction, Internal Rotation): This is perhaps the most specific test for provoking pain from hip impingement and intra-articular pathology. Even if the patient reports lateral or posterior pain during this maneuver, I consider it a significant finding if my clinical suspicion for hip joint pathology is high.
A Multifaceted Approach to Treatment
Effective management of hip OA requires a holistic, integrated strategy. There is no single magic bullet. The treatment plan must be tailored to the individual, addressing not only the pain but also the underlying biomechanical dysfunctions.
The Cornerstone: Physical Therapy and Chiropractic Care
I cannot overstate the importance of physical therapy. I often tell my patients, "We need physical therapy, physical therapy, and then some more physical therapy." The reason goes back to anatomy. The hip joint is the foundational structure, but the muscles surrounding it—the glutes, the core, the hip flexors—control its movement and absorb shock. If these muscles are weak, imbalanced, or not firing correctly, no injection or passive treatment will provide a lasting solution. The biomechanics of the entire kinetic chain must be restored.
This is where integrative chiropractic care plays a vital, synergistic role. As a chiropractor, my focus is on restoring proper joint mechanics and nervous system function. For a patient with hip OA, this involves:
Spinal and Pelvic Adjustments: Ensuring the lumbar spine and sacroiliac joints are moving correctly reduces compensatory stress on the hip joint. Misalignment in the pelvis can alter hip mechanics, accelerating wear and tear.
Soft Tissue Mobilization: Techniques like Active Release Technique (ART) or Graston Technique can address adhesions and tightness in the muscles and fascia surrounding the hip, improving flexibility and reducing muscular imbalances.
Neuromuscular Re-education: We work with patients to retrain proper movement patterns, ensuring that the correct muscles (such as the gluteus maximus) fire to stabilize the pelvis and hip during activities like walking, squatting, and climbing stairs.
By combining targeted chiropractic adjustments and soft-tissue work with a progressive physical therapy program, we create a stable, robust foundation that makes other treatments more effective and durable.
Evaluating Injection Therapies: Corticosteroids vs. Biologics
When conservative care is not enough to manage pain, injection therapies become a consideration. The choice of what to inject is critical, with significant differences in mechanisms and long-term outcomes.
Corticosteroid Injections
Corticosteroids have long been a mainstay treatment for joint pain due to their powerful anti-inflammatory effects. The American Academy of Orthopaedic Surgeons gives them a moderate recommendation for short-term pain reduction in hip OA. They can also serve a diagnostic purpose; if an injection of local anesthetic and steroid into the hip joint provides significant relief, it confirms the joint as the primary pain generator.
However, we must be realistic about their limitations. A large systematic review of 16 randomized controlled trials found that while steroid injections were more effective than a placebo at three months, there was no significant difference at six months. My conclusion from the available evidence is that corticosteroids can be a useful tool for short-term "fire-fighting"—calming down acute inflammation to allow a patient to engage more effectively in physical therapy—but they are not a long-term solution.
Platelet-Rich Plasma (PRP)
This is where regenerative medicine, specifically Platelet-Rich Plasma (PRP), offers a paradigm shift. PRP is a concentration of a patient's own platelets, which are rich in growth factors and signaling proteins that can modulate the inflammatory environment, recruit the body's own stem cells, and promote tissue healing.
The evidence for PRP in hip OA is growing and compelling.
A pooled analysis of eight randomized controlled trials found that PRP significantly reduced pain at multiple time points.
A major systematic review from 2022, which included eleven studies and over 1,000 patients, directly compared PRP to corticosteroids and other injectables. The conclusion was clear: PRP provided the greatest reduction in pain at the six-month mark.
This aligns with what we know about the biology: corticosteroids provide a temporary anti-inflammatory effect, while PRP initiates a longer-term healing and modulatory process. It takes longer to work—often 6-8 weeks to notice significant improvement—but the results are far more durable.
A Clinical Case Study: The Power of an Integrated Approach
Let me illustrate these concepts with a case from my own practice. I treated a 22-year-old elite college football linebacker who transferred to a new program. He had been suffering from debilitating "back pain" for six months. He had already undergone multiple epidural steroid injections, a medial branch block, and sciatic nerve injections with no benefit.
His hip examination was the key. He had severely limited internal rotation (only 15 degrees) and a positive FABER test. While his MRI did show an L5-S1 disc herniation, his physical exam pointed overwhelmingly to his hip. We obtained hip X-rays, which revealed a cam-type impingement lesion on his femoral head-neck junction.
Our treatment plan was multifaceted:
Start with the Foundation: We immediately initiated physical therapy focused on core stabilization and glute activation to address the biomechanical deficits.
Diagnostic and Therapeutic Injection: Because he needed to be functional for team workouts immediately, we performed a diagnostic injection of local anesthetic and a small amount of steroid into the hip joint. This completely eliminated his pain, confirming the hip as the source.
Regenerative Treatment: Once the spring season was over, we had a window for a definitive treatment. We performed a PRP injection into his hip joint.
The results were outstanding. His pain completely resolved. He went on to complete his next three years of college football without any time lost due to his hip or lumbar spine. This case beautifully illustrates the complexity of this anatomical region and the necessity of looking beyond the obvious diagnosis. It also showcases how a short-term solution (the steroid) can serve as a bridge to a long-term regenerative therapy (PRP), all built on the non-negotiable foundation of physical therapy and biomechanical correction.
The Future of Hip OA Treatment
The field of regenerative medicine is constantly evolving. While we have strong data supporting PRP, we are still refining the process. Key questions that leading researchers are exploring include:
Optimal Dosing: What is the ideal concentration of platelets for treating hip OA? Unlike the knee, the hip is a smaller, tighter joint capsule. Our experience and the data suggest lower volumes (perhaps 5-6 mL) are better tolerated and more effective than large volumes.
Injection Frequency: Some studies suggest a single, high-quality PRP injection may be more effective than a series of multiple injections. This is an area of active research.
Advanced Biologics: We are exploring the potential of other orthobiologics, such as lysate-concentrated plasma, which isolates specific anti-inflammatory and anti-degenerative proteins and may offer even more targeted therapeutic effects.
In my clinic, we use advanced benchtop systems to customize the biologic product. We can create a precise 6 mL volume of leukocyte-poor PRP that captures beneficial growth factors while minimizing inflammatory components, perfectly suited for the hip joint.
By integrating the foundational principles of chiropractic care and physical therapy with the latest evidence-based regenerative treatments, we can offer patients with hip osteoarthritis not just temporary relief, but a genuine opportunity for lasting functional improvement and a return to the active life they deserve.
References
Global Burden of Disease 2019 Study Collaborators. (2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet, 396(10258), 1204–1222. https://doi.org/10.1016/S0140-6736(20)30925-9
Katz, J. N., Arant, K. R., & Loeser, R. F. (2021). Diagnosis and treatment of hip and knee osteoarthritis: A review. JAMA, 325(6), 568–578. https://doi.org/10.1001/jama.2020.22171
Nüesch, E., Rutjes, A. W., Husni, E., Welch, V., & Jüni, P. (2011). Oral or transdermal opioids for osteoarthritis of the knee or hip. Cochrane Database of Systematic Reviews, (11). https://doi.org/10.1002/14651858.CD003115.pub3
Tang, Y., Li, S., Yin, Z., & Wang, P. (2022). Comparison of the Efficacy of Different Drugs in the Treatment of Hip Osteoarthritis: A Systematic Review and Network Meta-Analysis. Cartilage, 13(2), 194760352210875. https://doi.org/10.1177/19476035221087588
Veronesi, F., Giavaresi, G., Tschon, M., Borsari, V., Nicoli, A., & Fini, M. (2017). Clinical efficacy of intra-articular injections for the treatment of hip osteoarthritis: a systematic review. BMC Musculoskeletal Disorders, 18(1). https://doi.org/10.1186/s12891-017-1571-7
Williams, V. J., Pye, S. R., O’Neill, T. W., & Lunt, M. (2015). The impact of musculoskeletal disease on mortality: a 16-year follow-up study. Annals of the Rheumatic Diseases, 74(Suppl 2), 163-163. https://doi.org/10.1136/annrheumdis-2015-eular.5936
The information herein is not intended to replace a one-on-one relationship with a qualified healthcare professional or licensed physician and is not medical advice. We encourage you to make healthcare decisions based on your research and partnership with a qualified healthcare professional. Our information scope is limited to chiropractic, musculoskeletal, and physical medicine, as well as wellness, sensitive health issues, and functional medicine articles, topics, and discussions. We provide and facilitate clinical collaboration with specialists across disciplines. Each specialist is governed by their professional scope of practice and the jurisdiction in which they are licensed. We utilize functional health and wellness protocols to treat and support care for musculoskeletal injuries or disorders. Our videos, posts, topics, subjects, and insights cover clinical matters and issues that directly or indirectly support our clinical scope of practice. Our office has made a reasonable effort to provide supportive citations and identify relevant research studies for our posts. We provide copies of supporting research studies upon request to regulatory boards and the public.
We are here to help you and your family.
Blessings
Dr. Alex Jimenez, DC, MSACP, APRN, FNP-BC*, CCST, IFMCP, CFMP, ATN
email: coach@elpasofunctionalmedicine.com
Multidisciplinary Licensing & Board Certifications:
Licensed as a Doctor of Chiropractic (DC) in Texas & New Mexico*
Texas DC License #: TX5807, Verified: TX5807
New Mexico DC License #: NM-DC2182, Verified: NM-DC2182
Multi-State Advanced Practice Registered Nurse (APRN*) in Texas & Multi-States
Multi-State Compact APRN License by Endorsement (42 States)
Texas APRN License #: 1191402, Verified: 1191402 *
Florida APRN License #: 11043890, Verified: APRN11043890 *
New York APRN License #: N25929, Verified: APRN-N25929*
License Verification Link: Nursys License Verifier
* Prescriptive Authority Authorized
ANCC FNP-BC: Board Certified Nurse Practitioner*
Compact Status: Multi-State License: Authorized to Practice in 40 States*
Graduate with Honors: ICHS: MSN-FNP (Family Nurse Practitioner Program)
Degree Granted. Master's in Family Practice MSN Diploma (Cum Laude)
Dr. Alex Jimenez, DC, APRN, FNP-BC*, CFMP, IFMCP, ATN, CCST
My Digital Business Card
